IRF6 and multiple sclerosis: An interferon (INF) regulatory factor (IRF6) encoded by the IRF6 was significantly associated with increased risk of liver injury as identified in a case–control study of IFN-β1b-treated multiple sclerosis patients (OR: 8.3, 95% CI: 3.6–19.2; p = 2.3 × 10–8).